Margaret Tempero, MD, is a professor of medicine, director of the UCSF Pancreas Center, and editor-in-chief of JNCCN. Her research career focuses on pancreatic ductal adenocarcinoma, particularly in the area of experimental therapies. Dr. Tempero has served on the ASCO board and acted as its president. She is currently a member of the board of the ASCO Conquer Cancer Foundation.

She was co-director of the AACR/ASCO Methods in Clinical Cancer Research and taught in this course, as well as similar courses in Europe and Australia. She was the founding chair of the NCI Clinical Oncology Study Section and served as a member and chair of the NCI Board of Scientific Counselors Subcommittee A. She is a member of the scientific steering committee and chair of the clinical and translational studies section of the Cancer Prevention & Research Institute of Texas.

Dr. Tempero is or has been a member of the scientific advisory boards of the Lustgarten Foundation, the Pancreatic Cancer Action Network, the V Foundation, the Alberta Canada Cancer Board, and the EORTC. She was a member of the FDA Oncology Drug Advisory Committee. Additionally, she served as associate director and interim director of the UNMC Eppley Cancer Center. She is emeritus chair of the Department of Medical Oncology at UCSF.

Dr. Tempero was also the founding associate director and later director of research programs at the UCSF Helen Diller Family Comprehensive Cancer Center.